Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02315456 · ClinicalTrials.gov registry record · NA

Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser

A NA study of Capsulorhexis, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02315456 is a NA study of Capsulorhexis that has completed, run by Northwestern University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02315456, a NA study of Capsulorhexis, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The study compares anatomic outcomes of Intra Ocular Lens(IOL) placement with two methods of centration of the capsulorhexis- scanned capsule centration and pupil centration. It is hypothesized that scanned capsule centration provides more uniform(25% better) overlap of capsulorhexis margin over IOL optic compared to pupil centration.

Conditions Studied

Interventions

  • PROCEDURE capsulorhexis

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-12
Est. Completion 2016-08-09
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT02315456

The ClinicalTrials.gov registry entry for NCT02315456 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Capsulorhexis appearing as the primary indexed condition, and to 1 intervention - of which capsulorhexis is the first listed.

NCT02315456 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02315456 about?

NCT02315456 is a clinical study titled "Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser". The study compares anatomic outcomes of Intra Ocular Lens(IOL) placement with two methods of centration of the capsulorhexis- scanned capsule centration and pupil centration. It is hypothesized that scanned capsule centration provides more uniform(25% better) overlap of capsulorhexis margin over IOL...

What is the current status of trial NCT02315456?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-12. Estimated completion is 2016-08-09.

What conditions does trial NCT02315456 study?

This clinical trial studies the following conditions: Capsulorhexis.

What interventions are being tested in trial NCT02315456?

The interventions under investigation include: capsulorhexis (PROCEDURE).

Who is sponsoring clinical trial NCT02315456?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02315456 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.